Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
What clinical evidence exists for AOD-9604
What the Science Says About Combining NAD+ and 5-Amino-1MQ While no large-scale human trials have been published yet on the combined use of NAD+ therapy and 5-Amino-1MQ, interest in this area continues to grow, particularly in the fields of metabolic health and longevity medicine
Reducing dead space ensures the patient gets a full dose without wastage
The treatment also has important therapeutic benefits
AOD9604 and 3-AR Knockout Research Research using 3-adrenergic receptor knockout mice established that AOD9604s chronic in vivo lipolytic actions are mediated in part by modulating the expression of 3-AR in adipose tissue a mechanism shared with intact hGH with the restoration of depressed 3-AR RNA levels in obese animals to lean-comparable levels identified as a key pathway of sustained lipolytic sensitisation
